Important Notice to Long-Term Shareholders of Inspire Medical Systems, Inc. (INSP): Grabar Law Office Is Investigating Claims on Your Behalf

Core Viewpoint - Grabar Law Office is investigating claims on behalf of Inspire Medical Systems, Inc. shareholders regarding potential breaches of fiduciary duties by certain officers of the company [1] Investigation Basis - A securities fraud class action complaint alleges that Inspire Medical misled investors about the launch of its key product, the Inspire V sleep apnea device, claiming it met all necessary conditions for a successful launch, while in reality, the launch faced significant issues [3] - The complaint states that demand for Inspire V was low due to customers having excess inventory of older devices, and that the company failed to ensure proper uptake by clinicians and payors, leading to delays in adoption [3] - Following the revelation of these issues on August 4, 2025, Inspire Medical's stock price dropped by 32%, resulting in a loss of over $1.5 billion in shareholder value [3] Actions for Shareholders - Current shareholders who have held Inspire Medical shares since before August 6, 2024, can pursue corporate reforms, seek the return of funds to the company, and obtain a court-approved incentive award at no cost [2][4]